Nasdaq

Iambic Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)CIK 0001997038San Diego, CaliforniaFilings at SEC EDGAR

At a glance

Most recent filing on October 19, 2026 — a conversion by Catalio Capital Management, LP on Oct 16, 2026.

We hold 49 Form 4 lines, going back to October 16, 2026.

Insider trades

5 of 49 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 49. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Catalio Capital Management, LP 10% owner
742,546 sharesConversion
TradedOct 16, 2026FiledOct 19, 2026
Catalio Capital Management, LP 10% owner
1,458,290 sharesConversion
TradedOct 16, 2026FiledOct 19, 2026
Catalio Capital Management, LP 10% owner
122,684 sharesConversion
TradedOct 16, 2026FiledOct 19, 2026
Catalio Capital Management, LP 10% owner
731,187 sharesConversion
TradedOct 16, 2026FiledOct 19, 2026
Catalio Capital Management, LP 10% owner
1,141,878 sharesConversion
TradedOct 16, 2026FiledOct 19, 2026